Mark Sisco

Title: The Innovative Contributions of Mark Sisco

Introduction

Mark Sisco is a notable inventor based in New York, NY, who has made significant contributions to the field of wound healing. He holds a patent that addresses the issue of hypertrophic scarring, which can occur during the healing process of dermal wounds. His innovative approach utilizes antisense compounds to inhibit the expression of connective tissue growth factor (CTGF), thereby reducing scarring.

Latest Patents

Mark Sisco's most recent patent is titled "Method for reducing scarring during wound healing using antisense compounds directed to CTGF." This invention provides a method for reducing hypertrophic scarring resulting from dermal wound healing in a subject in need. It involves administering an antisense oligonucleotide that inhibits the expression of CTGF in an effective amount to achieve the desired reduction in scarring.

Career Highlights

Throughout his career, Mark Sisco has worked with prominent companies in the pharmaceutical industry. He has been associated with Excaliard Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc., where he has contributed to advancements in medical treatments and therapies.

Collaborations

Mark Sisco has collaborated with esteemed professionals in his field, including Thomas A. Mustoe and Nicholas M. Dean. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in wound healing.

Conclusion

Mark Sisco's work in developing methods to reduce scarring during wound healing showcases his commitment to improving patient outcomes. His patent and collaborations reflect his significant contributions to medical science and innovation.